Quipt Home Medical Corp (QIPT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Quipt Home Medical Corp stock (QIPT) is currently trading at $3.65. Quipt Home Medical Corp PS ratio (Price-to-Sales) is 0.61. Analyst consensus price target for QIPT is $3.65. WallStSmart rates QIPT as Sell.
- QIPT PE ratio analysis and historical PE chart
- QIPT PS ratio (Price-to-Sales) history and trend
- QIPT intrinsic value — DCF, Graham Number, EPV models
- QIPT stock price prediction 2025 2026 2027 2028 2029 2030
- QIPT fair value vs current price
- QIPT insider transactions and insider buying
- Is QIPT undervalued or overvalued?
- Quipt Home Medical Corp financial analysis — revenue, earnings, cash flow
- QIPT Piotroski F-Score and Altman Z-Score
- QIPT analyst price target and Smart Rating
Quipt Home Medical Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Quipt Home Medical Corp (QIPT) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, revenue growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Quipt Home Medical Corp (QIPT) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Revenue surging 32.00% year-over-year
Trading at 1.61x book value, attractively priced
Supporting Valuation Data
Quipt Home Medical Corp (QIPT) Areas to Watch (6)
Company is destroying shareholder value
Earnings declining -97.70%, profits shrinking
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Micro-cap company with very limited liquidity and high volatility
Moderate institutional interest at 37.29%
Supporting Valuation Data
Quipt Home Medical Corp (QIPT) Detailed Analysis Report
Overall Assessment
This company scores 40/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 3 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 1.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Revenue Growth, Price/Book. Valuation metrics including Price/Sales (0.61), Price/Book (1.61) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 32.00%.
The Bear Case
The primary concerns are Return on Equity, EPS Growth, Profit Margin. Growth concerns include EPS Growth at -97.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -9.31%, Operating Margin at 1.54%, Profit Margin at -4.03%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -9.31% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 32.00% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
QIPT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
QIPT's Price-to-Sales ratio of 0.61x trades at a deep discount to its historical average of 1.31x (35th percentile). The current valuation is 85% below its historical high of 3.97x set in Jun 2021, and 92% above its historical low of 0.32x in Nov 2025. Over the past 12 months, the PS ratio has expanded from ~0.4x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Quipt Home Medical Corp (QIPT) · HEALTHCARE › MEDICAL DISTRIBUTION
The Big Picture
Quipt Home Medical Corp is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 265M with 32% growth year-over-year. The company is currently unprofitable, posting a -403.0% profit margin.
Key Findings
Revenue growing at 32% YoY, reaching 265M. This pace significantly outperforms most MEDICAL DISTRIBUTION peers.
Generating 7M in free cash flow and 9M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -403.0% profit margin. The path to breakeven will be the key catalyst.
Earnings fell 98% YoY while revenue grew 32%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Growth sustainability: can Quipt Home Medical Corp maintain 32%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DISTRIBUTION industry trends, competitive moves, and regulatory changes that could impact Quipt Home Medical Corp.
Bottom Line
Quipt Home Medical Corp is a high-conviction growth story with revenue accelerating at 32% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -403.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Quipt Home Medical Corp(QIPT)
NASDAQ
HEALTHCARE
MEDICAL DISTRIBUTION
USA
Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.